Literature DB >> 18548094

Transient depletion of RUNX1/RUNX1T1 by RNA interference delays tumour formation in vivo.

N Martinez Soria, R Tussiwand, P Ziegler, M G Manz, O Heidenreich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18548094     DOI： 10.1038/leu.2008.157

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Destabilization of AETFC through C/EBPα-mediated repression of LYL1 contributes to t(8;21) leukemic cell differentiation.

Authors:  Meng-Meng Zhang; Na Liu; Yuan-Liang Zhang; Bowen Rong; Xiao-Lin Wang; Chun-Hui Xu; Yin-Yin Xie; Shuhong Shen; Jiang Zhu; Stephen D Nimer; Zhu Chen; Sai-Juan Chen; Robert G Roeder; Fei Lan; Lan Wang; Qiu-Hua Huang; Xiao-Jian Sun
Journal:  Leukemia       Date:  2019-02-12       Impact factor: 11.528

2.  Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding.

Authors:  A Ptasinska; S A Assi; D Mannari; S R James; D Williamson; J Dunne; M Hoogenkamp; M Wu; M Care; H McNeill; P Cauchy; M Cullen; R M Tooze; D G Tenen; B D Young; P N Cockerill; D R Westhead; O Heidenreich; C Bonifer
Journal:  Leukemia       Date:  2012-02-20       Impact factor: 11.528

3.  Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia.

Authors:  Sai Huang; Meng-Meng Jiang; Guo-Feng Chen; Kun Qian; Hong-Hao Gao; Wei Guan; Jin-Long Shi; An-Qi Liu; Jing Liu; Bian-Hong Wang; Yong-Hui Li; Li Yu
Journal:  Chin Med J (Engl)       Date:  2016-06-05       Impact factor: 2.628

4.  The leukemia-associated RUNX1/ETO oncoprotein confers a mutator phenotype.

Authors:  V J Forster; M H Nahari; N Martinez-Soria; A K Bradburn; A Ptasinska; S A Assi; S E Fordham; H McNeil; C Bonifer; O Heidenreich; J M Allan
Journal:  Leukemia       Date:  2015-06-08       Impact factor: 11.528

5.  A novel epigenetic AML1-ETO/THAP10/miR-383 mini-circuitry contributes to t(8;21) leukaemogenesis.

Authors:  Yonghui Li; Qiaoyang Ning; Jinlong Shi; Yang Chen; Mengmeng Jiang; Li Gao; Wenrong Huang; Yu Jing; Sai Huang; Anqi Liu; Zhirui Hu; Daihong Liu; Lili Wang; Clara Nervi; Yun Dai; Michael Q Zhang; Li Yu
Journal:  EMBO Mol Med       Date:  2017-07       Impact factor: 12.137

6.  Integrated genomic characterization of cancer genes in glioma.

Authors:  Aijun Liang; Bin Zhou; Wei Sun
Journal:  Cancer Cell Int       Date:  2017-10-13       Impact factor: 5.722

7.  MicroRNA let-7b downregulates AML1-ETO oncogene expression in t(8;21) AML by targeting its 3'UTR.

Authors:  Daniel T Johnson; Amanda G Davis; Jie-Hua Zhou; Edward D Ball; Dong-Er Zhang
Journal:  Exp Hematol Oncol       Date:  2021-02-02

8.  The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.

Authors:  Natalia Martinez-Soria; Lynsey McKenzie; Julia Draper; Anetta Ptasinska; Hasan Issa; Sandeep Potluri; Helen J Blair; Anna Pickin; Asmida Isa; Paulynn Suyin Chin; Ricky Tirtakusuma; Daniel Coleman; Sirintra Nakjang; Salam Assi; Victoria Forster; Mojgan Reza; Ed Law; Philip Berry; Dorothee Mueller; Cameron Osborne; Alex Elder; Simon N Bomken; Deepali Pal; James M Allan; Gareth J Veal; Peter N Cockerill; Christian Wichmann; Josef Vormoor; Georges Lacaud; Constanze Bonifer; Olaf Heidenreich
Journal:  Cancer Cell       Date:  2018-10-08       Impact factor: 38.585

9.  Identification of a dynamic core transcriptional network in t(8;21) AML that regulates differentiation block and self-renewal.

Authors:  Anetta Ptasinska; Salam A Assi; Natalia Martinez-Soria; Maria Rosaria Imperato; Jason Piper; Pierre Cauchy; Anna Pickin; Sally R James; Maarten Hoogenkamp; Dan Williamson; Mengchu Wu; Daniel G Tenen; Sascha Ott; David R Westhead; Peter N Cockerill; Olaf Heidenreich; Constanze Bonifer
Journal:  Cell Rep       Date:  2014-09-18       Impact factor: 9.423
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.